AC110619.2 | Uncharacterized protein | | | | |
|
| | Tissue enhanced | 0 |
ADAMTS6 | ADAM metallopeptidase with thrombospondin type 1 motif, 6 | | | | |
|
| Nucleus but not nucleoli | Tissue enhanced | 0 |
ADAMTSL4 | ADAMTS-like 4 | | | | |
|
| Plasma membrane Cytoplasm | Tissue enhanced | 0 |
ADRB1 | Adrenoceptor beta 1 | | | | |
|
| | Tissue enhanced | 0 |
AFF2 | AF4/FMR2 family, member 2 | | | | |
|
| | Tissue enhanced | 0 |
AGTR1 | Angiotensin II receptor, type 1 | | | | |
|
| | Tissue enhanced | 0 |
AKR1B15 | Aldo-keto reductase family 1, member B15 | | | | |
|
| | Tissue enhanced | 0 |
ALPPL2 | Alkaline phosphatase, placental-like 2 | | | | |
|
| | Tissue enhanced | 0 |
APLN | Apelin | | | | | |
| | Tissue enhanced | 0 |
APLNR | Apelin receptor | | | | |
|
| | Tissue enhanced | 0 |
AREG | Amphiregulin | | | | |
|
| Mitochondria | Tissue enhanced | 0 |
AREGB | Amphiregulin B | | | | |
|
| | Tissue enhanced | 0 |
ARID3A | AT rich interactive domain 3A (BRIGHT-like) | | | | |
|
| Cytoplasm Nucleoli Nucleus but not nucleoli Golgi apparatus | Tissue enhanced | 0 |
ATG9B | Autophagy related 9B | | | | | |
| | Tissue enhanced | 0 |
BIRC7 | Baculoviral IAP repeat containing 7 | | | | |
|
| | Tissue enhanced | 0 |
BMP5 | Bone morphogenetic protein 5 | | | | | |
| | Tissue enhanced | 0 |
C20orf202 | Chromosome 20 open reading frame 202 | | | | |
|
| | Tissue enhanced | 0 |
C5orf17 | Chromosome 5 open reading frame 17 | | | | |
|
| | Tissue enhanced | 0 |
CCNE1 | Cyclin E1 | | | | |
|
| Nucleus but not nucleoli | Tissue enhanced | 0 |
CCSAP | Centriole, cilia and spindle-associated protein | | | | |
|
| Nucleus but not nucleoli Cytoskeleton (Cytokinetic bridge) | Tissue enhanced | 0 |
CDH5 | Cadherin 5, type 2 (vascular endothelium) | | | | |
|
| | Tissue enhanced | 0 |
CGB7 | Chorionic gonadotropin, beta polypeptide 7 | | | | |
|
| Cytoplasm | Tissue enhanced | 0 |
CLDN6 | Claudin 6 | | | | |
|
| | Tissue enhanced | 0 |
CLEC1A | C-type lectin domain family 1, member A | | | | |
|
| | Tissue enhanced | 0 |
COL11A1 | Collagen, type XI, alpha 1 | | | | |
|
| Cytoskeleton (Microtubules) | Tissue enhanced | 0 |
COL15A1 | Collagen, type XV, alpha 1 | | | | |
|
| | Tissue enhanced | 0 |
COL4A1 | Collagen, type IV, alpha 1 | | | | |
|
| Nucleus but not nucleoli Cytoplasm | Tissue enhanced | 0 |
COL4A2 | Collagen, type IV, alpha 2 | | | | |
|
| Vesicles | Tissue enhanced | 0 |
COLEC12 | Collectin sub-family member 12 | | | | |
|
| | Tissue enhanced | 0 |
COX4I2 | Cytochrome c oxidase subunit IV isoform 2 (lung) | | | | |
|
| | Tissue enhanced | 0 |
CSF2RA | Colony stimulating factor 2 receptor, alpha, low-affinity (granulocyte-macrophage) | | | | |
|
| | Tissue enhanced | 0 |
CTB-167G5.5 | Uncharacterized protein | | | | | |
| | Tissue enhanced | 0 |
CTHRC1 | Collagen triple helix repeat containing 1 | | | | |
|
| Nucleus but not nucleoli | Tissue enhanced | 0 |
CYSLTR2 | Cysteinyl leukotriene receptor 2 | | | | |
|
| | Tissue enhanced | 0 |
CYTL1 | Cytokine-like 1 | | | | | |
| | Tissue enhanced | 0 |
DACT2 | Dishevelled-binding antagonist of beta-catenin 2 | | | | |
|
| Cytoplasm | Tissue enhanced | 0 |
DEPDC1B | DEP domain containing 1B | | | | |
|
| Golgi apparatus Nucleus but not nucleoli Cytoplasm | Tissue enhanced | 0 |
DIO3 | Deiodinase, iodothyronine, type III | | | | | |
| | Tissue enhanced | 0 |
DKK1 | Dickkopf WNT signaling pathway inhibitor 1 | | | | |
|
| Nucleus but not nucleoli Nuclear membrane Cytoplasm | Tissue enhanced | 0 |
DLX3 | Distal-less homeobox 3 | | | | |
|
| | Tissue enhanced | 0 |
DPRX | Divergent-paired related homeobox | | | | |
|
| | Tissue enhanced | 0 |
DSCR4 | Down syndrome critical region gene 4 | | | | |
|
| | Tissue enhanced | 0 |
EFHD1 | EF-hand domain family, member D1 | | | | |
|
| | Tissue enhanced | 0 |
EGFR | Epidermal growth factor receptor | | | | |
|
| Plasma membrane Cytoplasm | Tissue enhanced | 0 |
ENDOU | Endonuclease, polyU-specific | | | | |
|
| | Tissue enhanced | 0 |
ENPP1 | Ectonucleotide pyrophosphatase/phosphodiesterase 1 | | | | |
|
| | Tissue enhanced | 0 |
ERVMER34-1 | Endogenous retrovirus group MER34, member 1 | | | | |
|
| Nucleus Cytoplasm | Tissue enhanced | 0 |
F5 | Coagulation factor V (proaccelerin, labile factor) | | | | |
|
| | Tissue enhanced | 0 |
FAM124B | Family with sequence similarity 124B | | | | |
|
| | Tissue enhanced | 0 |
FAM162B | Family with sequence similarity 162, member B | | | | |
|
| | Tissue enhanced | 0 |